Related Experiment Video

Updated: Jan 10, 2026

Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research
03:13

Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research

Published on: November 3, 2023

2.8K

siRNA-mediated therapeutic approaches improve acute kidney injury and limit its worsening

Xijian Wang1,2, Xinzhong Huang2, Bin Yang1,3

  • 1Nantong-Leicester Joint Institute of Kidney Science, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China.

Frontiers in Pharmacology
|November 24, 2025
PubMed

Insights

Small interfering RNA (siRNA) offers a promising gene therapy approach to treat acute kidney injury (AKI). This review explores siRNA

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Genetics

Background:

  • Acute kidney injury (AKI) is a major global health concern with high mortality and progression to chronic kidney disease (CKD).
  • Current treatments for AKI are limited, lacking targeted molecular interventions for its underlying mechanisms and progression.
  • RNA interference (RNAi) technology, specifically small interfering RNA (siRNA), presents a novel therapeutic strategy for gene modulation in AKI.

Purpose of the Study:

  • To review the potential of siRNA-mediated gene therapy for mitigating AKI and preventing its progression.
  • To discuss the properties, advantages, and research advancements in siRNA for AKI treatment.
  • To explore challenges and future prospects of siRNA-based drug development for AKI.

Main Methods:

  • Review of existing literature on siRNA technology and its application in AKI.
  • Analysis of siRNA chemical modifications and delivery systems for targeted AKI treatment.
  • Discussion of therapeutic approaches and clinical applications of siRNA in AKI.

Main Results:

  • siRNA technology demonstrates potential for precise gene modulation in AKI.
  • Advancements in siRNA chemical modifications and delivery systems enhance targeted AKI therapies.
  • Various therapeutic strategies utilizing siRNA for AKI are under investigation.

Conclusions:

  • siRNA-mediated gene therapy holds significant promise for treating AKI and preventing its chronicity.
  • Further research into targeted delivery systems and overcoming challenges is crucial for clinical translation.
  • siRNA represents a potential breakthrough in AKI management, benefiting researchers and clinicians.
Keywords:
acute kidney injurychemical modificationsdelivery systemssmall interfering RNAtherapeutic targets

More Related Videos

Delivery of Exogenous Artificially Synthesized miRNA Mimic to the Kidney Using Polyethylenimine Nanoparticles in Several Kidney Disease Mouse Models07:01

Delivery of Exogenous Artificially Synthesized miRNA Mimic to the Kidney Using Polyethylenimine Nanoparticles in Several Kidney Disease Mouse Models

Published on: May 10, 2022

1.9K
Nephrotoxin Microinjection in Zebrafish to Model Acute Kidney Injury07:58

Nephrotoxin Microinjection in Zebrafish to Model Acute Kidney Injury

Published on: July 17, 2016

9.2K

Related Concept Videos

Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
284
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
249
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
536
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
858
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
371
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
785